Bipolar and Related Disorders

84 soru

Soru 1Soru →

Match each clinical scenario describing an adverse pharmacological event in a patient being treated for bipolar disorder to the most accurate underlying mechanism of the interaction.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 42-year-old man with bipolar I disorder presents to the clinic with severe ataxia, coarse tremors, and confusion. Physical exam shows bilateral horizontal nystagmus. Mental status exam reveals disorientation. He recently started lisinopril and hydrochlorothiazide for hypertension. His serum creatinine is 1.41.4 mg/dL (baseline 0.90.9 mg/dL).
A 24-year-old man with a history of brief, distinct periods of euphoric mood and decreased need for sleep presents to the outpatient clinic with profound sadness and fatigue. He is prescribed paroxetine monotherapy. He returns to the ED two weeks later exhibiting severe agitation, pressured speech, flight of ideas, and grandiosity.
A 31-year-old man with bipolar depression presents to the emergency department with a rapidly spreading, painful maculopapular rash and mucosal ulcerations. A novel mood stabilizer was recently initiated at a standard titration dose while he was concurrently maintained on divalproex sodium.
A 28-year-old woman with rapid-cycling bipolar disorder presents to her obstetrician reporting missed menses. She experiences an unintended pregnancy despite perfect adherence to combined oral contraceptives. A new maintenance psychiatric medication was added two months ago.
A 35-year-old woman treated with a fixed-dose combination of fluoxetine and olanzapine for acute bipolar depression presents to the ED with altered mental status. Temperature is 39.2∘C39.2^\circ C. Physical exam reveals prominent inducible clonus in the lower extremities and diaphoresis. She recently took over-the-counter dextromethorphan.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches pair each clinical presentation with its specific pharmacokinetic or pharmacodynamic drug interaction mechanism, correctly linking thiazides to lithium toxicity, SSRI monotherapy to manic switch, valproate-lamotrigine to glucuronidation inhibition, carbamazepine to CYP450 induction, and fluoxetine-dextromethorphan to serotonin syndrome.
Each clinical scenario corresponds to a classic, high-yield pharmacological complication encountered in bipolar disorder management. Recognizing these specific medication interactions (CYP450 induction, glucuronidation inhibition, renal clearance changes) is critical for safe prescribing.

Adım Adım Çözüm

1
Analyze each clinical vignette to identify the underlying adverse effect or complication.
Patient 1 has lithium toxicity; Patient 2 has a manic switch; Patient 3 has Stevens-Johnson syndrome/TEN; Patient 4 has OCP failure; Patient 5 has serotonin syndrome.
Accurate recognition of the clinical toxidrome or event is required before identifying the pharmacological mechanism.
2
Identify the interacting medications in each scenario.
Patient 1: lithium + ACEi/thiazide. Patient 2: SSRI monotherapy in unrecognized bipolar disorder. Patient 3: valproate + lamotrigine. Patient 4: carbamazepine + OCPs. Patient 5: fluoxetine + dextromethorphan.
Drug-drug interactions in psychiatry frequently rely on precise CYP450, UGT, or renal clearance alterations.
3
Map the medication combination to the correct physiological or molecular mechanism.
Matches are finalized based on the established pharmacokinetic and pharmacodynamic profiles of mood stabilizers and antipsychotics.
This confirms the understanding of maintenance therapy management and its pitfalls.

Anahtar Kavram

Pharmacokinetic and pharmacodynamic interactions of mood stabilizers and antipsychotics in the management of bipolar disorder.
Soru 2Soru →

A psychiatric clinical pharmacist is reviewing the pharmacotherapy regimens of six patients being treated for various phases of bipolar disorder. Each scenario involves a critical drug-drug interaction, a specific administration requirement, or a major prescribing pitfall. Match each clinical scenario with the precise pharmacokinetic or pharmacodynamic rationale that governs its clinical management.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A patient stabilized on lithium carbonate is prescribed hydrochlorothiazide for newly diagnosed essential hypertension.
A patient maintained on divalproex sodium is initiated on lamotrigine to manage a breakthrough episode of bipolar depression.
A patient with rapid-cycling bipolar disorder treated with carbamazepine requests a prescription for a combined oral contraceptive pill.
A patient administered sublingual asenapine for acute mania is instructed to strictly avoid eating or drinking for 10 minutes post-dose.
A patient prescribed ziprasidone for bipolar maintenance therapy is heavily counseled to take the medication exclusively alongside a 500-calorie meal.
A patient with bipolar I disorder presenting with a major depressive episode is inappropriately prescribed paroxetine monotherapy by an outside provider.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Lithium + HCTZ pairs with compensatory proximal tubular reabsorption; Valproate + Lamotrigine pairs with UGT inhibition; Carbamazepine + OCP pairs with CYP3A4 induction; Asenapine pairs with extensive first-pass metabolism; Ziprasidone pairs with dietary fat dependence; Paroxetine monotherapy pairs with the risk of treatment-emergent affective switch.
Bipolar disorder management requires meticulous attention to pharmacokinetic and pharmacodynamic interactions. Lithium is renally cleared and highly sensitive to volume shifts caused by thiazides, which paradoxically increase its proximal reabsorption. Valproate inhibits UGT, necessitating a slower lamotrigine titration to avoid Stevens-Johnson syndrome. Carbamazepine is a potent CYP3A4 auto-inducer that diminishes the efficacy of OCPs. Specific atypical antipsychotics have unique absorption profiles: asenapine requires transmucosal absorption to bypass first-pass metabolism, while ziprasidone requires dietary fat to be absorbed. Finally, SSRI monotherapy (paroxetine) is a major pharmacodynamic pitfall due to the risk of inducing acute mania.

Adım Adım Çözüm

1
Evaluate the lithium and hydrochlorothiazide combination.
Matches with compensatory enhancement of proximal tubular reabsorption.
Thiazides inhibit the Na+/Cl- cotransporter in the distal tubule. The resulting volume depletion leads to increased proximal reabsorption of sodium and lithium, precipitating lithium toxicity.
2
Evaluate the divalproex sodium and lamotrigine combination.
Matches with inhibition of UDP-glucuronosyltransferase (UGT).
Valproate inhibits the glucuronidation of lamotrigine, dramatically increasing lamotrigine levels and the risk of life-threatening rashes like Stevens-Johnson syndrome.
3
Evaluate the carbamazepine and oral contraceptive pill combination.
Matches with induction of cytochrome P450 3A4 (CYP3A4).
Carbamazepine upregulates hepatic CYP3A4, which increases the clearance of oral contraceptives, causing therapeutic failure (unintended pregnancy).
4
Evaluate the sublingual asenapine administration instructions.
Matches with extensive hepatic first-pass metabolism.
If patients drink or eat immediately after sublingual asenapine, the drug is washed into the stomach and undergoes heavy first-pass metabolism, rendering it ineffective.
5
Evaluate the ziprasidone administration instructions.
Matches with adequate gastrointestinal absorption depending on dietary fat.
Ziprasidone's absorption is highly food-dependent; it must be taken with a substantial (>500 calorie) meal to achieve adequate therapeutic serum levels.
6
Evaluate the paroxetine monotherapy scenario in bipolar I disorder.
Matches with unopposed monoaminergic reuptake inhibition causing an affective switch.
SSRIs given without a mood stabilizer in bipolar I patients can precipitate a severe manic episode.

Anahtar Kavram

Pharmacokinetics, pharmacodynamics, and critical drug-drug interactions of mood stabilizers and atypical antipsychotics in Bipolar Disorder.
Tahmini Süre:2m 30s
Soru 3Soru →

Match each clinical vignette describing a medication-specific complication, adverse effect, or pharmacokinetic requirement to the most likely offending psychotropic agent used in the context of bipolar disorder.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 28-year-old woman treated for bipolar I disorder presents with amenorrhea and bilateral galactorrhea. Laboratory evaluation reveals a negative serum beta-hCG and an elevated serum prolactin level.
A 45-year-old man on maintenance pharmacotherapy for bipolar disorder is found to have a serum sodium of 124 mEq/L (normal: 135-145) on routine lab monitoring. He is clinically euvolemic, and his urine osmolality is elevated.
A 32-year-old man is prescribed a second-generation antipsychotic for acute bipolar depression. To ensure adequate systemic absorption and therapeutic efficacy, the physician instructs him to take the medication with a meal of at least 350 calories.
A 50-year-old man on long-term maintenance therapy complains of excessive thirst and urinating 6 to 8 liters per day. His urine specific gravity is low, and his symptoms do not improve after a period of water deprivation.
A 24-year-old woman with a history of recurrent severe depression and a first-degree relative with bipolar disorder is prescribed a selective serotonin reuptake inhibitor. Two weeks later, she requires hospitalization for severe agitation, pressured speech, and a decreased need for sleep.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches are: Galactorrhea and amenorrhea with Risperidone; Euvolemic hyponatremia with Carbamazepine; Required administration with a 350-calorie meal with Lurasidone; Nephrogenic diabetes insipidus with Lithium carbonate; and Antidepressant-induced manic switch with Fluoxetine.
Each medication utilized in bipolar disorder management has a distinct profile. Risperidone is highly associated with hyperprolactinemia. Carbamazepine causes SIADH (hyponatremia). Lurasidone necessitates administration with significant food (>350 calories) for absorption. Lithium causes nephrogenic diabetes insipidus by antagonizing ADH. Fluoxetine, an SSRI, can induce an acute manic episode if given as monotherapy to a patient with bipolar disorder.

Adım Adım Çözüm

1
Analyze the endocrine/reproductive vignette.
Identified hyperprolactinemia.
Among the options, Risperidone is the antipsychotic most strongly associated with tuberoinfundibular dopamine blockade and subsequent elevated prolactin.
2
Analyze the electrolyte abnormality vignette.
Identified euvolemic hyponatremia consistent with SIADH.
Carbamazepine frequently causes SIADH, requiring routine serum sodium monitoring.
3
Analyze the pharmacokinetic vignette.
Identified the specific caloric intake requirement for absorption.
Lurasidone specifically requires a minimum 350-calorie meal for adequate bioavailability; taking it on an empty stomach drastically reduces its efficacy.
4
Analyze the renal/urinary vignette.
Identified nephrogenic diabetes insipidus.
Lithium carbonate is a classic cause of acquired nephrogenic DI due to its interference with ADH action at the collecting duct, leading to massive polyuria and polydipsia.
5
Analyze the psychiatric complication vignette.
Identified an antidepressant-induced manic switch.
Fluoxetine, a selective serotonin reuptake inhibitor, should not be used as monotherapy for depression in patients with a history of or high risk for bipolar disorder due to the risk of precipitating mania.

Anahtar Kavram

Pharmacotherapy for Bipolar Disorder: Specific Adverse Effects and Administration Requirements
Soru 4Soru →

A 27-year-old male graphic designer is brought to the emergency department by his roommate. The patient has not left his bedroom for the past 3 weeks, has been eating very little, and sleeps up to 14 hours a day. The roommate notes that for the last 5 days, the patient has been repeatedly whispering to himself and claiming that "the authorities have hidden listening devices in the ceiling." Past psychiatric history is notable for an involuntary psychiatric admission 4 years ago due to severe agitation, grandiose beliefs of having superhuman abilities, and pressured speech; that episode lasted 12 days. The patient's medical history is significant for a recent ankle sprain, for which he is currently taking tramadol. Mental status examination reveals a disheveled appearance, poor eye contact, profound psychomotor retardation, and a restricted affect. He confirms hearing a male voice calling him a "traitor." Vital signs are within normal limits. Which of the following is the most appropriate management plan for this patient?

Cevabı ve açıklamayı göster

Cevap: Admit to the inpatient psychiatric unit and start quetiapine

Cevap

Admit to the inpatient psychiatric unit and start quetiapine
The patient's history of a prior manic episode necessitating hospitalization confirms a diagnosis of Bipolar I disorder. He is currently presenting with a severe major depressive episode complicated by mood-congruent psychotic features (delusions of surveillance and derogatory auditory hallucinations) and a dangerous decline in self-care (poor oral intake, extreme hypersomnia). Inpatient psychiatric admission is indicated for patient safety and acute stabilization. The pharmacologic treatment of choice for severe bipolar depression with psychotic features is an atypical antipsychotic that has proven efficacy in the depressive phase of bipolar disorder, such as quetiapine. Quetiapine will simultaneously target the severe depressive symptoms and the acute psychosis.

Adım Adım Çözüm

1
Analyze the past psychiatric history
The patient had a 12-day episode of severe agitation, grandiosity, and pressured speech requiring hospitalization.
This establishes a definitive history of a manic episode, confirming the diagnosis of Bipolar I disorder.
2
Evaluate the current presentation and timeline
The patient is experiencing a 3-week major depressive episode with concurrent psychotic features (delusions of persecution, auditory hallucinations) that began 5 days ago.
This determines that the current diagnosis is Bipolar I disorder, current episode depressed, severe, with mood-congruent psychotic features.
3
Determine the optimal treatment setting and pharmacotherapy
The patient requires inpatient admission due to severe functional impairment (poor oral intake, profound withdrawal), and should be started on an atypical antipsychotic like quetiapine.
Inpatient admission ensures safety. Quetiapine is a first-line monotherapy that effectively treats both bipolar depression and the concurrent psychotic symptoms without risking a manic switch.

Anahtar Kavram

Patients with Bipolar I disorder who present with a severe depressive episode and psychotic features require treatment with an atypical antipsychotic approved for bipolar depression (e.g., quetiapine, lurasidone) and often necessitate inpatient stabilization. Antidepressant monotherapy must be strictly avoided.
Tahmini Süre:1m 30s
Soru 5Soru →

A 26-year-old female dental hygienist comes to the outpatient psychiatry clinic reporting two months of profound sadness, lack of motivation, and sleeping 12 to 14 hours a day. She states she has lost interest in her usual hobbies and feels intense, inappropriate guilt regarding a recent decline in her work performance. She has gained 5 kg (11 lb) over this period. Her medical history is unremarkable, and she currently takes no medications. Vital signs and physical examination are within normal limits. When specifically asked about past mood fluctuations, the patient recalls a distinct five-day period during her sophomore year of college when she felt "supercharged." During that time, she required only 3 hours of sleep per night, started multiple complex art projects, and felt highly productive. That period did not result in hospitalization or significant functional impairment. Mental status examination today reveals a cooperative woman with a blunted affect, psychomotor retardation, and slow speech. She denies suicidal ideation, auditory hallucinations, and paranoia. Which of the following is the most appropriate next step in pharmacotherapy?

Cevabı ve açıklamayı göster

Cevap: Quetiapine

Cevap

Quetiapine
The correct answer is Quetiapine. This patient's current presentation of hypersomnia, hyperphagia, and profound sadness indicates a major depressive episode. However, her history of a five-day period of elevated mood, decreased need for sleep, and increased goal-directed activity without significant functional impairment or hospitalization perfectly describes a hypomanic episode. Therefore, her diagnosis is Bipolar II disorder. The first-line pharmacological treatment for acute bipolar depression includes certain second-generation antipsychotics (such as quetiapine, lurasidone, and cariprazine) or the mood stabilizer lamotrigine. Quetiapine provides acute relief of depressive symptoms without the high risk of inducing a manic switch.

Adım Adım Çözüm

1
Analyze the patient's presenting symptoms and psychiatric history.
The patient is currently in a major depressive episode (sadness, hypersomnia, weight gain) but has a history of a distinct 5-day period of elevated mood, decreased need for sleep, and increased activity without severe impairment.
Identifying past mood episodes is necessary to differentiate unipolar major depressive disorder from bipolar spectrum disorders.
2
Establish the correct diagnosis based on DSM-5 criteria.
The diagnosis is Bipolar II disorder, characterized by at least one major depressive episode and at least one hypomanic episode (lasting ≥\geq 4 days).
Accurate diagnosis dictates the pharmacological approach and prevents harmful prescribing errors.
3
Select the appropriate pharmacotherapy for acute bipolar depression.
Quetiapine is selected. All traditional antidepressant monotherapies are contraindicated.
Antidepressant monotherapy can precipitate a manic switch. Quetiapine is an FDA-approved second-generation antipsychotic for treating acute bipolar depression.

Anahtar Kavram

Patients presenting with major depressive episodes must be screened for past manic or hypomanic episodes to rule out bipolar disorder; if bipolar disorder is diagnosed, antidepressant monotherapy is contraindicated due to the risk of a manic switch, and agents like quetiapine, lurasidone, or lamotrigine should be used.
Soru 6Soru →

A 28-year-old male fitness coach presents to the psychiatry clinic with a 5-week history of profound sadness, anhedonia, and sleeping up to 14 hours a day. He reports significant fatigue and difficulty concentrating on his clients' workout plans. Past psychiatric history reveals an episode 3 years ago characterized by 10 days of feeling "invincible," sleeping only 2 hours nightly, and maxing out several credit cards to start an ill-advised supplement company. His medical history is unremarkable. Vital signs are within normal limits. Mental status examination reveals psychomotor retardation, poor eye contact, and a constricted affect. Which of the following pharmacological interventions are appropriate for the acute management of this patient's current episode? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Prescribe lurasidone; Prescribe olanzapine combined with fluoxetine

Cevap

The appropriate interventions are prescribing lurasidone and prescribing olanzapine combined with fluoxetine.
The patient's presentation of a major depressive episode accompanied by a clear history of a manic episode (decreased need for sleep, grandiosity, and severe impulsivity lasting at least 7 days) confirms the diagnosis of Bipolar I Disorder, currently in a depressed episode. The pharmacological treatment of acute bipolar depression differs significantly from unipolar depression. First-line treatments with demonstrated efficacy and safety include lurasidone, quetiapine, cariprazine, and the olanzapine-fluoxetine combination. These agents target depressive symptoms without excessively risking mood destabilization.

Adım Adım Çözüm

1
Evaluate the current presenting symptoms.
The patient has a 5-week history of profound sadness, anhedonia, hypersomnia, and fatigue.
These symptoms fulfill the DSM-5 criteria for a major depressive episode.
2
Analyze the patient's past psychiatric history.
The patient experienced a 10-day episode of grandiosity, decreased need for sleep, and severe impulsivity (financial irresponsibility).
This distinct period of elevated mood and increased energy lasting over 7 days confirms a past manic episode.
3
Formulate the correct overarching diagnosis.
The combination of a lifetime manic episode and a current depressive episode yields a diagnosis of Bipolar I Disorder, current episode depressed.
A single manic episode is sufficient to diagnose Bipolar I Disorder, distinguishing it from Major Depressive Disorder.
4
Determine the appropriate evidence-based pharmacological treatments.
Lurasidone and the olanzapine-fluoxetine combination are selected.
These medications are first-line treatments with established efficacy for acute bipolar depression that do not carry the high risk of mood destabilization seen with antidepressant monotherapy.

Anahtar Kavram

The first-line pharmacological management of acute bipolar depression includes agents such as lurasidone, quetiapine, cariprazine, or the olanzapine-fluoxetine combination, while strictly avoiding antidepressant monotherapy.
Soru 7Soru →

A 25-year-old woman is brought to the outpatient psychiatric clinic by her sister due to a 4-week history of profound sadness, lack of motivation, and sleeping up to 14 hours daily. For the past week, the patient has been hearing an unfamiliar voice repeatedly telling her she is "hopeless and already dead." Her past psychiatric history is notable for a 3-week hospitalization two years ago when she exhibited extremely rapid speech, required only two hours of sleep per night, and harbored grandiose delusions about being a spiritual prophet. Following her discharge from that hospitalization, she returned to her baseline functioning and experienced no mood or psychotic symptoms until the current episode. The patient currently takes no medications. Vital signs are within normal limits. Laboratory evaluation reveals a thyroid-stimulating hormone (TSH) level of 1.4μU/mL1.4 \mu U/mL (normal: 0.5−5.0μU/mL0.5-5.0 \mu U/mL) and a free thyroxine (T4) level of 0.8ng/dL0.8 ng/dL (normal: 0.9−1.7ng/dL0.9-1.7 ng/dL). Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Initiate quetiapine

Cevap

Initiate quetiapine
The patient has a history of a distinct manic episode (decreased need for sleep, grandiose delusions, severe impairment requiring hospitalization), which establishes a diagnosis of Bipolar I Disorder. She is currently experiencing an acute major depressive episode with mood-congruent psychotic features. The most appropriate treatment for acute bipolar depression includes agents like quetiapine, lurasidone, or cariprazine. Quetiapine is particularly appropriate here as it is a second-generation antipsychotic that effectively treats bipolar depression while also addressing the patient's acute psychotic symptoms (auditory hallucinations).

Adım Adım Çözüm

1
Analyze the patient's psychiatric history.
The history of a manic episode with grandiose delusions two years ago establishes a diagnosis of Bipolar I Disorder.
A single manic episode is sufficient to diagnose Bipolar I Disorder, which dictates all future pharmacological management of mood episodes.
2
Evaluate the current clinical presentation.
The patient is experiencing a severe major depressive episode with mood-congruent psychotic features (hearing voices saying she is dead).
Identifying the current phase of the bipolar illness (acute depression with psychosis) is necessary to select an agent that targets both mood and psychosis.
3
Interpret the laboratory findings.
The normal TSH with a borderline low Free T4 rules out primary hypothyroidism as the cause of her severe depression.
Medical causes of depressive symptoms must be ruled out, but misinterpreting minor lab variations can lead to inappropriate treatment.
4
Select the most appropriate pharmacotherapy.
Quetiapine is selected as it is FDA-approved for bipolar depression and possesses antipsychotic properties.
Standard antidepressants (SSRIs) are contraindicated as monotherapy in Bipolar I due to the risk of manic switch, and the patient requires an agent that treats both depression and psychosis.

Anahtar Kavram

Management of acute bipolar depression with psychotic features involves avoiding antidepressant monotherapy and utilizing an atypical antipsychotic like quetiapine or lurasidone.
Soru 8Soru →

A 2626-year-old woman comes to the psychiatric clinic for a follow-up evaluation regarding persistent low mood, hypersomnia, and severe fatigue. She has an established diagnosis of bipolar II disorder. Six weeks ago, she began taking lamotrigine for a major depressive episode. Her dosage was gradually increased according to standard protocols to a maintenance dose of 200 mg200 \text{ mg} daily, which she has been taking consistently for the past 22 weeks. Despite medication adherence, the patient states she feels "just as depressed as before" and struggles to complete basic daily tasks. Her medical history is notable for polycystic ovary syndrome, which is well-controlled with a combined ethinyl estradiol and norgestimate oral contraceptive pill. Vital signs are within normal limits. Laboratory testing reveals a serum lamotrigine concentration of 1.2μg/mL1.2 \mu\text{g/mL} (therapeutic reference range: 3−15μg/mL3-15 \mu\text{g/mL}).

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Increase the dosage of lamotrigine

Cevap

Increase the dosage of lamotrigine
The correct intervention is to increase the dosage of lamotrigine. Lamotrigine is primarily metabolized in the liver via glucuronidation by the enzyme UDP-glucuronosyltransferase 1A4 (UGT1A4). Estrogen, a key component of combined oral contraceptive pills, is a potent inducer of UGT1A4. This enzymatic induction significantly accelerates the clearance of lamotrigine, often reducing serum concentrations by 50%50\% or more. Because this patient is symptomatic and has a confirmed subtherapeutic lamotrigine level resulting from this known pharmacokinetic interaction, the appropriate clinical step is to increase the lamotrigine dosage to achieve therapeutic efficacy. Often, female patients taking concurrent estrogen-containing contraceptives require up to double the standard maintenance dose of lamotrigine.

Adım Adım Çözüm

1
Identify the primary clinical problem.
The patient has bipolar II depression and is symptomatic despite taking a standard maintenance dose of lamotrigine, with objective laboratory evidence of a subtherapeutic drug concentration.
Establishing the baseline clinical status is necessary to determine if the current regimen is adequate.
2
Analyze the patient's medication list for potential pharmacokinetic interactions.
The patient is taking a combined oral contraceptive pill containing ethinyl estradiol.
Drug-drug interactions are a primary cause of subtherapeutic medication levels in psychiatry, particularly with mood stabilizers.
3
Determine the mechanism of the drug-drug interaction.
Estrogen is a potent inducer of UDP-glucuronosyltransferase 1A4 (UGT1A4), the primary hepatic enzyme responsible for the glucuronidation and clearance of lamotrigine.
Understanding this metabolic pathway explains why the lamotrigine level is significantly lower than expected for a compliant patient on a 200 mg200 \text{ mg} dose.
4
Select the safest and most effective clinical intervention.
The lamotrigine dosage must be increased to overcome the accelerated clearance and achieve a therapeutic serum level.
Adjusting the dose addresses the underlying pharmacokinetic issue without abandoning an effective first-line treatment or precipitating dangerous withdrawal toxicities.

Anahtar Kavram

Estrogen-containing oral contraceptives induce the glucuronidation (via UGT1A4) of lamotrigine, significantly decreasing its serum concentration and requiring a higher maintenance dose.
Tahmini Süre:1m 30s
Soru 9Soru →

A 29-year-old woman is brought to the psychiatrist by her sister due to worsening isolation and profound sadness over the past 55 weeks. The patient sleeps 1414 hours daily and frequently hears voices stating, "You are a vessel of sin." Three years ago, she experienced a 1010-day period during which she slept only 33 hours per night, spoke incessantly, and aggressively attempted to start a new company despite having no related experience. She has a history of primary hypothyroidism, for which she takes daily levothyroxine. Vital signs are normal. Laboratory results demonstrate a TSH of 2.22.2 μ\mu U/mL (normal: 0.40.4-4.04.0 μ\mu U/mL) and a free T4 of 1.31.3 ng/dL (normal: 0.90.9-1.71.7 ng/dL). Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Initiate quetiapine

Cevap

Initiate quetiapine
The correct intervention is to initiate quetiapine. This patient's current presentation of profound sadness, hypersomnia, and mood-congruent auditory hallucinations represents a major depressive episode with psychotic features. Her psychiatric history of a 10-day episode characterized by decreased need for sleep, pressured speech, and grandiose behaviors definitively establishes a diagnosis of Bipolar I disorder. The standard of care for acute bipolar depression includes specific second-generation antipsychotics like quetiapine or lurasidone, which provide robust antidepressant effects while inherently protecting against treatment-emergent mania. In this case, quetiapine is particularly advantageous as it will simultaneously treat her psychotic symptoms.

Adım Adım Çözüm

1
Evaluate the current clinical presentation and duration of symptoms.
The patient is experiencing a major depressive episode with mood-congruent psychotic features (auditory hallucinations), lasting for 5 weeks.
To accurately characterize the current phase of her psychiatric illness.
2
Analyze the patient's psychiatric history.
The patient has a clear history of a prior manic episode (10 days of decreased sleep, pressured speech, grandiosity).
A history of true mania shifts the diagnosis from Major Depressive Disorder or a primary psychotic disorder to Bipolar I Disorder.
3
Assess the medical history and laboratory findings.
Her TSH and free T4 are entirely within normal limits.
To rule out a medical etiology (e.g., undertreated hypothyroidism) as the cause of her current severe depressive symptoms.
4
Determine the most appropriate pharmacotherapy for the established diagnosis.
Quetiapine should be initiated.
Quetiapine is a second-generation antipsychotic that is uniquely approved for the treatment of acute bipolar depression, and it will concurrently address her psychotic symptoms. Crucially, it avoids the risk of a manic switch associated with antidepressant monotherapy.

Anahtar Kavram

Bipolar I depression with psychotic features requires treatment with an agent that addresses both depression and psychosis safely, such as quetiapine, while strictly avoiding antidepressant monotherapy.
Soru 10Soru →

A 25-year-old male fitness instructor presents to a primary care clinic reporting a 6-week history of feeling 'completely drained of energy.' He states that he has lost interest in his usual workout routines, struggles to concentrate on his business, and has been sleeping up to 13 hours a day. His medical history is unremarkable, and he currently takes no medications. Upon further questioning about his past psychiatric history, he recalls a 5-week period approximately two years ago when he felt 'invincible.' During that time, he slept only 3 hours per night, spoke incredibly fast, and spontaneously purchased extremely expensive gym equipment that led to bankruptcy. He also harbored an intense belief that he possessed a telepathic ability to communicate with elite athletes worldwide; this belief entirely resolved when his energy levels returned to baseline. His vital signs are within normal limits. Mental status examination today reveals a blunted affect and psychomotor retardation, with no current delusional thought processes or suicidal ideation. Which of the following is the most appropriate next step in pharmacologic management?

Cevabı ve açıklamayı göster

Cevap: Initiate lamotrigine

Cevap

Initiate lamotrigine
This patient meets the diagnostic criteria for Bipolar I Disorder based on his distinct history of a manic episode (elevated mood, decreased need for sleep, rapid speech, reckless financial behavior, and psychotic features lasting more than 1 week). He is currently presenting with a major depressive episode. The most appropriate pharmacologic management for acute bipolar depression involves initiating a medication with proven efficacy for this phase that carries a low risk of precipitating a manic switch. Lamotrigine is a mood stabilizer that is highly effective for bipolar depression and is commonly used as a first-line agent. Other appropriate first-line options include lithium, cariprazine, or a combination of olanzapine and fluoxetine.

Adım Adım Çözüm

1
Identify the patient's current clinical state based on the presenting symptoms.
The patient exhibits depressed mood, anhedonia, hypersomnia, and psychomotor retardation lasting 6 weeks, indicating a major depressive episode.
Establishing the current pole of the mood disorder is essential for selecting the correct acute treatment phase.
2
Analyze the past psychiatric history to determine the overarching diagnosis.
The history of a 5-week episode characterized by decreased need for sleep, rapid speech, reckless spending, and grandiose delusions (telepathy) confirms a prior manic episode with psychotic features.
A single manic episode in a patient's lifetime definitively establishes a diagnosis of Bipolar I Disorder, regardless of current symptoms.
3
Select the most appropriate pharmacologic intervention for bipolar depression.
First-line therapies for bipolar depression include mood stabilizers like lamotrigine, lithium, or specific atypical antipsychotics. Antidepressant monotherapy must be avoided.
Treating bipolar depression requires medications that lift the depressed mood without inducing a switch into mania.

Anahtar Kavram

Diagnosis and management of Bipolar I Disorder, current episode depressed, prioritizing mood-stabilizing agents to avoid antidepressant-induced manic switching.

Alternatif Yöntem

Lithium, cariprazine, or lurasidone could also be selected as appropriate first-line monotherapies for acute bipolar depression in this patient.
Tahmini Süre:1m 30s
Soru 11Soru →

A 29-year-old male presents to the outpatient clinic reporting a 4-week history of persistently depressed mood, anhedonia, severe fatigue, sleeping 12 to 14 hours a day, and a 4-kg (9-lb) weight gain. He states that he is struggling to concentrate at his job as a data analyst. He denies any suicidal ideation. His past medical history is notable for an episode three years ago during which he experienced a 10-day period of decreased need for sleep (sleeping only 2 hours per night), remarkably elevated mood, grandiosity, and impulsive behavior that resulted in significant credit card debt. He did not seek medical attention at that time, and the symptoms eventually resolved. Vital signs are normal. Physical examination is unremarkable. Laboratory studies show a thyroid-stimulating hormone (TSH) level of 1.4 mU/L and a free thyroxine (T4) level of 1.2 ng/dL. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Begin quetiapine therapy

Cevap

The most appropriate next step in management is to prescribe an atypical antipsychotic approved for bipolar depression, such as quetiapine.
The correct approach is to begin quetiapine therapy. This patient is currently experiencing a major depressive episode but has a history of a distinct manic episode (10 days of elevated mood, decreased need for sleep, and severe functional impairment in the form of significant debt). This clinical picture is diagnostic of Bipolar I Disorder, currently in a depressed episode. The standard of care for acute bipolar depression includes specific atypical antipsychotics (such as quetiapine, lurasidone, or cariprazine) or established mood stabilizers (such as lithium or valproate). Quetiapine has well-demonstrated efficacy for bipolar depression and does not carry the risk of precipitating mania.

Adım Adım Çözüm

1
Analyze the patient's current symptoms.
The patient presents with depressed mood, anhedonia, hypersomnia, fatigue, and weight gain for 4 weeks.
To determine the current clinical syndrome, which meets the criteria for a major depressive episode.
2
Evaluate the patient's past psychiatric history.
The patient had a 10-day episode of decreased sleep, grandiosity, and impulsive behavior leading to severe impairment (significant debt).
To differentiate between unipolar major depressive disorder and bipolar disorder. The past episode meets the criteria for a manic episode, establishing a diagnosis of Bipolar I Disorder.
3
Select the appropriate pharmacotherapy for acute bipolar depression.
Quetiapine therapy is selected.
Quetiapine, lurasidone, and cariprazine are first-line, FDA-approved monotherapies for bipolar depression. Antidepressant monotherapy must be avoided due to the risk of inducing a manic switch.

Anahtar Kavram

Patients presenting with depressive episodes must be carefully screened for a history of mania or hypomania. Treatment of bipolar depression requires mood stabilizers or specific atypical antipsychotics (e.g., quetiapine, lurasidone); antidepressant monotherapy is contraindicated due to the high risk of precipitating a manic switch.
Soru 12Soru →

A 30-year-old male chef is brought to the emergency department by his husband due to worsening suicidal ideation. For the past month, the patient has experienced profound sadness, a 7-kg (15-lb) weight gain, hypersomnia, and a complete lack of energy. He has a history of major depressive disorder diagnosed in his early twenties. His husband reports that three years ago, the patient had a 3-week period where he slept only two hours per night, spoke so rapidly he was difficult to interrupt, and developed grandiose delusions that he had discovered the cure for aging. These delusions completely resolved when his mood returned to baseline. The patient is currently not taking any prescribed medications but consumes a high-dose St. John's wort supplement daily. Vital signs are within normal limits. Mental status examination reveals a cooperative patient with depressed mood, flattened affect, and psychomotor retardation. He denies current hallucinations or delusions. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Initiate lurasidone

Cevap

Initiate lurasidone
This patient's history of a distinct period of decreased need for sleep, rapid speech, and grandiose delusions is diagnostic of a prior manic episode. Because the psychotic symptoms (delusions) resolved concurrently with the mood symptoms, the correct diagnosis is Bipolar I Disorder, not schizoaffective disorder. He is currently presenting with an acute bipolar depressive episode. First-line pharmacotherapy for acute bipolar depression includes specific second-generation antipsychotics such as lurasidone, quetiapine, or cariprazine. Lurasidone effectively targets the depressive symptoms without carrying the high risk of inducing a manic switch.

Adım Adım Çözüm

1
Analyze the patient's past psychiatric history.
The patient had a distinct 3-week period of decreased sleep, rapid speech, and grandiose delusions that resolved with his mood.
Identifying past episodes of mania or hypomania is required to differentiate bipolar disorder from major depressive disorder.
2
Determine the correct diagnosis.
The history of a manic episode establishes a diagnosis of Bipolar I Disorder. The current presentation is an acute depressive episode.
The presence of delusions during the manic episode indicates bipolar disorder with psychotic features. Because the psychosis did not occur outside the mood episode, schizoaffective disorder is ruled out.
3
Select the appropriate pharmacotherapy.
Lurasidone is selected as it is a first-line agent for acute bipolar depression.
Antidepressant monotherapy must be avoided to prevent a manic switch, and potential drug interactions with St. John's wort must be considered.

Anahtar Kavram

Patients with Bipolar I Disorder presenting with an acute depressive episode should be treated with mood stabilizers or specific second-generation antipsychotics (e.g., lurasidone, quetiapine) to avoid the high risk of antidepressant-induced manic switch.
Soru 13Soru →

A 26-year-old female graduate student is brought to the emergency department by her roommate. For the past month, the patient has exhibited profound sadness, a 4.5-kg (10-lb) weight loss, and severe psychomotor retardation. She sleeps 14 hours a day and refuses to attend her classes. During the interview, she stares blankly and admits she has been hearing a persistent voice saying she is "a fraud who deserves to die." The roommate reports that two years ago, the patient had a distinct 3-week period where she barely slept, spoke incredibly fast, bought thousands of dollars of unneeded laboratory equipment on credit, and claimed she had independently deciphered the human genome. That prior episode culminated in a 5-day psychiatric hospitalization. Her urine toxicology screen is negative. Which of the following is the most accurate diagnosis and most appropriate initial pharmacotherapy for this patient?

Cevabı ve açıklamayı göster

Cevap: Bipolar I disorder; initiate quetiapine

Cevap

The most accurate diagnosis is Bipolar I disorder, and the most appropriate treatment is to initiate quetiapine.
The correct answer accurately identifies that a single lifetime episode of mania (characterized by grandiosity, decreased sleep, rapid speech, and hospitalization) is sufficient to diagnose Bipolar I disorder, regardless of the current presentation. Because the patient is currently in a severe depressive episode with psychotic features, treatment must target both mood stabilization and psychosis. Quetiapine is a second-generation antipsychotic with robust, FDA-approved efficacy in acute bipolar depression, and it will simultaneously manage her auditory hallucinations without the risk of precipitating a manic switch.

Adım Adım Çözüm

1
Analyze the patient's psychiatric history from two years ago.
The history of a 3-week period of elevated mood, grandiosity, decreased need for sleep, and hospitalization indicates a severe manic episode.
Identifying any lifetime history of mania is required to correctly differentiate bipolar I disorder from unipolar major depressive disorder.
2
Evaluate the patient's current clinical presentation.
The patient exhibits depressed mood, significant weight loss, hypersomnia, psychomotor retardation, and auditory hallucinations for 1 month, indicating an acute major depressive episode with mood-congruent psychotic features.
Establishing the current phase of the bipolar illness dictates the immediate pharmacological intervention.
3
Select a safe and effective pharmacotherapy for the current diagnosis.
Quetiapine is selected over antidepressant monotherapy or isolated mood stabilizers.
Antidepressant monotherapy is contraindicated in bipolar disorder due to the risk of inducing a manic switch. An atypical antipsychotic like quetiapine is FDA-approved for bipolar depression and will concurrently address the psychotic features.

Anahtar Kavram

Patients presenting with acute depression must be screened for a history of mania or hypomania to rule out Bipolar Disorder. Antidepressant monotherapy is contraindicated in bipolar depression due to the risk of manic switch; first-line treatments include quetiapine, lurasidone, or olanzapine-fluoxetine combination.
Soru 14Soru →

A 48-year-old man is evaluated in the outpatient clinic for a 6-week history of persistently low mood, severe fatigue, anhedonia, and waking up at 3:00 AM every day without being able to return to sleep. He reports feeling "completely empty" and has unintentionally lost 4.5 kg4.5\text{ kg} (10 lb10\text{ lb}) over this period. His past medical history is significant for chronic lumbar radiculopathy, for which he takes daily tramadol. His past psychiatric history reveals a psychiatric hospitalization at age 32 for a 3-week episode of abnormally euphoric mood, hypersexuality, decreased need for sleep, and impulsive spending that led to significant debt. Vital signs are within normal limits. Physical examination is unremarkable. Mental status examination reveals a disheveled man with psychomotor retardation, restricted affect, and depressed mood. He denies active suicidal ideation. Laboratory studies show a thyroid-stimulating hormone (TSH) level of 1.8 μU/mL1.8\text{ }\mu\text{U/mL} and a free thyroxine (T4) level of 1.2 ng/dL1.2\text{ ng/dL}. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Initiate lurasidone

Cevap

The most appropriate next step is to initiate lurasidone, a second-generation antipsychotic approved for bipolar depression.
The patient's current presentation of low mood, anhedonia, weight loss, and early morning awakenings meets the criteria for a major depressive episode. However, his history of a prior hospitalization for euphoric mood, decreased need for sleep, and impulsivity is highly characteristic of a manic episode. Therefore, his correct diagnosis is bipolar I disorder, currently in a depressed episode. The standard of care for acute bipolar depression includes specific second-generation antipsychotics (e.g., lurasidone, quetiapine, cariprazine) or mood stabilizers (e.g., lithium, lamotrigine). Initiating lurasidone is the most appropriate next step to effectively treat his depressive symptoms without the risk of inducing mania.

Adım Adım Çözüm

1
Identify the patient's current clinical syndrome.
The patient is presenting with a major depressive episode (low mood, fatigue, anhedonia, early morning awakening, weight loss).
Establishing the current phase of the illness is necessary to guide symptom-specific therapy.
2
Review the patient's past psychiatric history.
The patient has a history of a distinct manic episode at age 32 (euphoria, hypersexuality, decreased sleep, impulsive spending requiring hospitalization).
A history of mania changes the diagnosis from major depressive disorder to bipolar I disorder.
3
Select the appropriate pharmacotherapy for bipolar depression while avoiding contraindications.
Lurasidone is selected over antidepressant monotherapies (which risk manic switch) and over medications that interact with his current regimen.
Lurasidone is approved for acute bipolar depression. Antidepressants like sertraline or venlafaxine are avoided as monotherapy in bipolar I disorder. Selegiline is avoided due to interactions with tramadol.

Anahtar Kavram

Patients presenting with depressive episodes must be screened for a history of mania; if present, the diagnosis is bipolar I disorder, and treatment involves mood stabilizers or specific atypical antipsychotics (e.g., lurasidone, quetiapine) rather than antidepressant monotherapy.
Soru 15Soru →

A 34-year-old woman comes to the outpatient psychiatry clinic reporting that she "cannot get out of bed" and feels completely hopeless. Over the past 6 weeks, she has experienced a persistently depressed mood, slept 14 hours a day, gained 4.5 kg (10 lb), and suffered from profound fatigue. She admits to passive suicidal ideation but denies any active plan. Her past psychiatric history is notable for a major depressive episode at age 22, for which she was prescribed paroxetine. Three weeks after starting paroxetine, she developed a severely elevated mood, rapid and pressured speech, decreased need for sleep (2 hours per night), and grandiose delusions resulting in psychiatric hospitalization. She was stabilized on a medication that she discontinued 5 years ago because she "felt fine." Her medical history includes type 2 diabetes mellitus, hypertension, and osteoarthritis. Current medications are metformin, lisinopril, hydrochlorothiazide, and daily ibuprofen. Her vital signs show a blood pressure of 145/90 mmHg. Her BMI is 38 kg/m². Laboratory studies reveal a hemoglobin A1c of 9.2%. Mental status examination shows marked psychomotor retardation, a flattened affect, and a depressed mood. Which of the following is the most appropriate next step in pharmacotherapy for this patient's current psychiatric symptoms?

Cevabı ve açıklamayı göster

Cevap: Initiate lurasidone

Cevap

Initiate lurasidone
The patient's history of a manic episode (hospitalization, grandiose delusions, decreased need for sleep) following paroxetine use indicates a definitive diagnosis of Bipolar I disorder. She is currently experiencing a severe, acute bipolar depressive episode. The primary goal of pharmacotherapy is to treat the depression without precipitating a manic switch, while minimizing adverse effects given her severe medical comorbidities. Lurasidone is an atypical antipsychotic FDA-approved for acute bipolar depression. Crucially, it has a highly favorable metabolic profile (weight and lipid neutral), making it the safest and most effective choice for a patient with severe obesity and uncontrolled type 2 diabetes (HbA1c 9.2%). Furthermore, it does not have severe pharmacokinetic interactions with her antihypertensives or NSAIDs.

Adım Adım Çözüm

1
Diagnose the underlying psychiatric disorder based on past history.
Bipolar I disorder, currently in a severe major depressive episode.
The history of hospitalization for mania (grandiose delusions, decreased need for sleep) triggered by paroxetine confirms Bipolar I disorder, not recurrent major depressive disorder.
2
Identify appropriate medication classes for acute bipolar depression.
Options include lurasidone, quetiapine, cariprazine, olanzapine-fluoxetine, or lithium.
Standard antidepressant monotherapies (SSRIs, SNRIs) must be explicitly avoided due to the high risk of precipitating a manic switch.
3
Evaluate the safety of lithium given the patient's current medication list.
Lithium is unsafe and highly contraindicated in this specific clinical context.
The concurrent use of ACE inhibitors (lisinopril), thiazide diuretics (hydrochlorothiazide), and NSAIDs (ibuprofen) drastically reduces renal lithium clearance, placing the patient at immediate risk for severe lithium toxicity.
4
Evaluate the remaining atypical antipsychotics against the patient's medical comorbidities.
Lurasidone is the most appropriate and optimal choice.
Olanzapine-fluoxetine and quetiapine have high metabolic liabilities and would exacerbate her uncontrolled type 2 diabetes (HbA1c 9.2%) and severe obesity. Lurasidone is metabolically neutral.

Anahtar Kavram

Pharmacologic management of acute bipolar depression in patients with complex medical comorbidities and polypharmacy.
Soru 16Soru →

A 34-year-old man presents via telehealth for a follow-up visit. Over the past four weeks, he has experienced persistent low mood, hypersomnia, extreme fatigue, and a loss of interest in his usual activities. Five years ago, he was hospitalized for an episode characterized by grandiosity, pressured speech, and a significantly decreased need for sleep. He has not taken any medications for the past six months. Which of the following are appropriate pharmacological treatments for this patient's current condition? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Quetiapine; Lurasidone; Olanzapine and fluoxetine combination

Cevap

The correct treatments are quetiapine, lurasidone, and the olanzapine and fluoxetine combination.
The patient's history of a manic episode requiring hospitalization confirms a diagnosis of bipolar I disorder. He is currently presenting with an acute bipolar depressive episode. The goal of treatment is to alleviate depressive symptoms without inducing a manic switch. Quetiapine, lurasidone, and the olanzapine-fluoxetine combination are all first-line, FDA-approved treatments for acute bipolar depression. They provide both mood-stabilizing and antidepressant effects.

Adım Adım Çözüm

1
Diagnose the patient's underlying psychiatric disorder based on his history.
The patient has a history of an episode featuring grandiosity, pressured speech, and decreased need for sleep leading to hospitalization, which defines a manic episode. Therefore, his overarching diagnosis is bipolar I disorder.
Accurate diagnosis of bipolar disorder is necessary because depressive episodes in bipolar disorder must be treated differently than unipolar major depressive disorder.
2
Identify the patient's current clinical state.
The patient is currently experiencing a major depressive episode (low mood, hypersomnia, fatigue, anhedonia).
Treatment selection depends on the current phase of bipolar disorder (e.g., acute mania, acute depression, or maintenance).
3
Select appropriate pharmacotherapy for acute bipolar depression.
Appropriate options include quetiapine, lurasidone, or the olanzapine-fluoxetine combination. Antidepressant monotherapy must be avoided.
Antidepressant monotherapy can precipitate a manic switch in patients with bipolar disorder.

Anahtar Kavram

Acute depressive episodes in bipolar I disorder should be treated with specific second-generation antipsychotics (e.g., quetiapine, lurasidone) or combinations (e.g., olanzapine-fluoxetine) rather than antidepressant monotherapy, which carries a high risk of inducing mania.
Soru 17Soru →

An emergency department physician evaluates a 31-year-old man who presents with a 4-week history of severe depressed mood, hypersomnia, and a 6-kg (13.2-lb) weight gain. He recently took a leave of absence from his job as an accountant because he "lacks the mental energy to look at spreadsheets." Review of his electronic medical record reveals a prior hospitalization one year ago for acute agitation, pressured speech, and decreased need for sleep lasting 10 days; during that admission, he was convinced he had discovered a secret formula for infinite energy. He currently takes no medications and has no other medical conditions. Vital signs are within normal limits. Laboratory evaluation shows a normal comprehensive metabolic panel, negative urine toxicology screen, and a normal thyroid-stimulating hormone (TSH) level. The physician is formulating a comprehensive management plan. Which of the following statements regarding the diagnosis and management of this patient are correct? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Quetiapine monotherapy is an appropriate first-line pharmacological intervention for his current presentation.; Routine screening of fasting plasma glucose and a lipid panel is indicated before and during his planned psychopharmacologic treatment.

Cevap

The correct statements are that quetiapine monotherapy is an appropriate first-line treatment, and that routine screening of fasting plasma glucose and a lipid panel is indicated.
The patient's history of a manic episode with psychotic features (hospitalization for agitation, pressured speech, decreased need for sleep, and grandiose delusions) establishes a diagnosis of Bipolar I disorder. His current symptoms of hypersomnia, weight gain, and severe depressed mood represent an acute bipolar depressive episode. First-line pharmacotherapy for bipolar depression includes quetiapine, lurasidone, or lithium. Because quetiapine and other second-generation antipsychotics are associated with a risk of metabolic syndrome, standard of care requires obtaining a baseline fasting plasma glucose and lipid panel, and monitoring these parameters regularly during treatment.

Adım Adım Çözüm

1
Analyze the patient's psychiatric history.
The patient had a 10-day episode of elevated mood, pressured speech, decreased sleep, and grandiose delusions requiring hospitalization.
To establish a baseline diagnosis of Bipolar I disorder, which requires at least one manic episode.
2
Evaluate the current clinical presentation.
The patient is experiencing a 4-week period of severe depressed mood, hypersomnia, weight gain, and inability to work.
To diagnose an acute major depressive episode, which, in the context of his history, confirms the current phase is acute bipolar depression.
3
Determine the appropriate pharmacological interventions and necessary diagnostic workup.
First-line treatment for bipolar depression includes specific second-generation antipsychotics (e.g., quetiapine, lurasidone). Initiation of these medications requires baseline and ongoing metabolic monitoring. Antidepressant monotherapy must be avoided.
To formulate a safe and effective management plan while avoiding interventions that could precipitate a manic switch or cause severe drug interactions.

Anahtar Kavram

Diagnosis of Bipolar I Disorder and appropriate management of acute bipolar depression, including avoiding antidepressant monotherapy and ensuring metabolic monitoring for second-generation antipsychotics.
Soru 18Soru →

A 46-year-old woman is evaluated in the psychiatric clinic for an acute bipolar depressive episode. She has a history of bipolar I disorder with multiple past hospitalizations for severe mania. Her medical history includes hypertension, chronic lower back pain, and Hashimoto thyroiditis. Her current medications are lisinopril, naproxen (taken daily), and levothyroxine. Laboratory studies show a normal serum creatinine with an estimated glomerular filtration rate (eGFR) of 95 mL/min/1.73m² and a normal thyroid-stimulating hormone (TSH) level. The psychiatrist plans to initiate lithium carbonate for her current depressive episode and for long-term maintenance.

Which of the following are appropriate steps in the management of this patient prior to or during the initiation of lithium therapy? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Discontinue lisinopril and transition to amlodipine for blood pressure control; Instruct the patient to discontinue naproxen and use acetaminophen for analgesia; Obtain a baseline electrocardiogram (ECG) to evaluate for conduction abnormalities

Cevap

The correct steps are discontinuing lisinopril in favor of amlodipine, replacing naproxen with acetaminophen, and obtaining a baseline ECG.
Safe initiation of lithium requires managing dangerous drug interactions and performing age-appropriate medical screening. Lisinopril (ACE inhibitor) and naproxen (NSAID) both significantly decrease renal lithium clearance and must be replaced with safe alternatives like amlodipine and acetaminophen. Furthermore, patients over age 40 require a baseline ECG prior to lithium initiation due to the risk of conduction abnormalities.

Adım Adım Çözüm

1
Analyze the patient's current medication list for pharmacokinetic interactions with lithium.
Identify lisinopril (an ACE inhibitor) and naproxen (an NSAID) as high-risk interacting drugs.
Lithium has a narrow therapeutic index, and its renal clearance is significantly decreased by ACE inhibitors and NSAIDs, which can precipitate life-threatening lithium toxicity.
2
Determine appropriate substitutions for the interacting medications.
Select amlodipine (a calcium channel blocker) instead of lisinopril, and acetaminophen instead of naproxen.
Calcium channel blockers and acetaminophen do not significantly alter renal lithium clearance and are safe alternatives for blood pressure and pain management in this context.
3
Evaluate the patient's age and cardiovascular risk for necessary pre-treatment screening.
Identify the need for a baseline electrocardiogram (ECG).
The patient is 46 years old, which meets the guideline threshold (age > 40) for a baseline ECG prior to lithium initiation to rule out underlying cardiac conduction disease.
4
Evaluate the proposed alternative or adjunctive psychiatric interventions for safety and efficacy.
Reject paroxetine monotherapy and prophylactic hydrochlorothiazide.
SSRI monotherapy risks a manic switch in bipolar I disorder, and starting a thiazide would drastically increase lithium levels and toxicity risk.

Anahtar Kavram

Pre-treatment workup and pharmacokinetic drug interactions of lithium therapy in bipolar disorder.
Soru 19Soru →

A 23-year-old woman comes to the clinic reporting profound sadness, low energy, and poor concentration over the past 6 weeks. She sleeps up to 12 hours a day and has lost interest in her usual hobbies. Her medical history is notable for a psychiatric hospitalization three years ago. At that time, she experienced a two-week period of feeling 'invincible,' requiring only 2 to 3 hours of sleep per night, and impulsively spending her entire savings on luxury handbags. Her current vital signs and physical examination are unremarkable. Laboratory results, including a complete blood count, comprehensive metabolic panel, and thyroid-stimulating hormone (TSH) level, are within normal limits. Which of the following is the most appropriate initial medication for this patient's current symptoms?

Cevabı ve açıklamayı göster

Cevap: Lithium carbonate

Cevap

Lithium carbonate
The correct answer is Lithium carbonate. This patient's current presentation of prolonged sadness and hypersomnia represents a major depressive episode. However, her history of a severe, hospitalized episode characterized by a decreased need for sleep, grandiosity, and excessive spending confirms a diagnosis of bipolar I disorder. The cornerstone of treatment for bipolar depression includes mood stabilizers (such as lithium or valproate) and certain second-generation antipsychotics (such as quetiapine or lurasidone). Lithium is highly effective in treating acute bipolar depression and serves as an excellent maintenance therapy to prevent future manic and depressive relapses.

Adım Adım Çözüm

1
Analyze the current clinical presentation.
The patient has a 6-week history of depressed mood, hypersomnia, and anhedonia, indicating a major depressive episode.
To determine the acuity and phase of the current mood disturbance.
2
Evaluate the past psychiatric history.
The patient had a previous 2-week episode of grandiosity, decreased need for sleep, and excessive spending requiring hospitalization, which meets the criteria for a manic episode.
To differentiate between major depressive disorder (unipolar) and bipolar disorder.
3
Establish the diagnosis.
Bipolar I disorder, current episode depressed.
A lifetime history of at least one manic episode defines Bipolar I disorder, regardless of the current symptom presentation.
4
Select the appropriate pharmacotherapy.
Lithium carbonate.
Lithium is a first-line agent for acute bipolar depression. Antidepressant monotherapy is contraindicated due to the risk of inducing a manic switch.

Anahtar Kavram

Patients presenting with depressive symptoms must be screened for a history of mania. Bipolar depression requires treatment with mood stabilizers (e.g., lithium, valproate) or approved atypical antipsychotics; antidepressant monotherapy is contraindicated due to the risk of precipitating a manic switch.
Tahmini Süre:45s
Soru 20Soru →

A 21-year-old male university student is evaluated in the student health center for worsening fatigue, hypersomnia, and feelings of worthlessness over the past month. He states that he is failing his classes and feels "it would be better if I just went to sleep and never woke up." Review of his medical record reveals a prior psychiatric hospitalization at age 19 for a week-long episode of decreased need for sleep, grandiosity, and reckless spending. He currently takes no medications and uses no illicit substances. The physician is formulating a comprehensive management plan. Which of the following statements regarding his diagnosis and pharmacological management are correct? Select all that apply.

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Initiation of quetiapine monotherapy is an appropriate first-line treatment for his current episode; Baseline renal function and thyroid panel testing should be obtained if lithium therapy is selected

Cevap

The correct statements are that quetiapine monotherapy is an appropriate first-line treatment, and that baseline renal function and thyroid panel testing should be obtained if lithium therapy is selected.
This patient's history of a full manic episode (lasting at least 1 week with severe symptoms) confirms a diagnosis of Bipolar I Disorder. He is currently presenting with a severe acute bipolar depressive episode. Quetiapine monotherapy is FDA-approved and widely considered a first-line treatment for acute bipolar depression, as it treats depressive symptoms without a high risk of inducing mania. Alternatively, lithium could be used for treatment; however, because lithium is renally excreted and can cause nephrogenic diabetes insipidus, chronic kidney disease, and thyroid dysfunction (hypothyroidism), standard pre-treatment workup mandates baseline assessment of renal function (BUN/creatinine) and a thyroid panel.

Adım Adım Çözüm

1
Identify the patient's primary diagnosis based on psychiatric history.
The patient has a history of a week-long episode of decreased sleep, grandiosity, and reckless spending, which meets the criteria for a manic episode, establishing a diagnosis of Bipolar I Disorder.
Accurate psychiatric diagnosis is required to select appropriate pharmacotherapy and avoid contraindicated medications.
2
Determine the nature of the current presentation.
The patient is currently experiencing a severe major depressive episode with suicidal ideation.
Treatment must specifically target the acute depressive phase without destabilizing the patient's underlying mood disorder.
3
Evaluate the pharmacological options and pre-treatment requirements for bipolar depression.
First-line treatments include quetiapine, lurasidone, or lithium. SSRI monotherapy must be avoided due to the risk of a manic switch. If lithium is chosen, baseline renal and thyroid tests are mandatory.
Standard of care for bipolar depression mandates avoiding unchecked serotonin elevation and monitoring for known organ toxicities of mood stabilizers.

Anahtar Kavram

Pharmacological management and pre-treatment workup of acute bipolar depression
Sayfa 1 / 5Sonraki
Bipolar and Related Disorders Alıştırma Soruları — USMLE Step 2 CK | Examkin